遺伝子発現解析市場 : 2029年までの世界予測

Report Overview

The gene expression analysis market is projected to reach USD 6.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 8.1% during the forecast period.

遺伝子発現解析市場は、2024年の推定42億米ドルから2029年までに62億米ドルに達すると予測されており、予測期間中のCAGRは8.1%です。
The growth of this market can be attributed to the growing investments in genomics research and the availability of government funding for genetic studies further contributes to the market’s expansion. As the field continues to evolve, with a deeper understanding of gene regulation and molecular mechanisms, the gene expression analysis market is poised for continued growth and innovation.

“The PCR instrument segment accounted for the largest share by instruments in 2023.”
In 2023, the PCR segment accounted for the largest share of instruments sub-segment of product & service in the global gene expression analysis market. PCR instruments are widely adopted across various industries, including pharmaceuticals, biotechnology, academic research, clinical diagnostics, and forensic sciences. This broad application range contributes to the substantial market share of PCR instruments.

““The Asia Pacific region is grows at the highest CAGR in the gene expression analysis market during the forecast period of 2024-2029.”
The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. This region is s anticipated to experience rapid growth, fueled by expanding proteomics and genomics research, augmented research funding, amplified investments from pharmaceutical and biotechnology enterprises, and rising awareness surrounding personalized therapeutics. India and China are expected to display the highest growth in the Asia Pacific region, particularly due to the rise in affordability and awareness related to the benefits of diagnosis.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXOs and Directors – 30%, and Executives- 25%
• By Region: North America -45%, Europe -20%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc (US)
• Bio-Rad Laboratories Inc. (US)
• Illumina Inc (US)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche (Switzerland)
• Revvity (US)
• PacBio (US)
• Agilent Technologies Inc (US)
• Oxford Gene Technology IP Limited (UK)
• BGI (China)
• Eurofins Scientific (Luxembourg)
• Standard BioTools (US)
• Oxford Nanopore Technologies plc (UK)
• GenScript (US)
• Takara Bio Inc (Japan)
• 10x Genomics (US)
• Zymo Research Corporation (US)
• Twist Bioscience (US)
• Promega Corporation (US)
• LGC Limited (UK)
• CD Genomics (US)
• NanoString Technologies Inc. (US)
• BioSpyder, Inc (US)
• Integrated DNA Technologies, Inc (US)
• New England Biolabs (US).

Research Coverage:
This research report categorizes the gene expression analysis market by product & service (instruments, reagents & consumables and services (gene expression analysis service and bioinformatics service)), application (clinical diagnostics, drug discovery & development, and other applications (developmental biology, pharmacogenomics, environmental response, forensic research, agricultural research)) , end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users (clinical laboratories, CROs, forensic laboratories, agricultural & environmental organizations)), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and trends influencing the growth of the gene expression analysis market. The report conducts in-depth analysis of major industry players, offering insights into their business profiles, product/service offerings, and strategic initiatives including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments within the gene expression analysis market. Furthermore, it encompasses competitive analysis of leading players as well as emerging startups within the gene expression analysis market ecosystem.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene expression analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Advancement in gene editing technologies, increasing funding initiatives for genomic research, growing preference for therapeutic application, declining sequencing cost), restraints (high cost of instruments & consumables, concerns associated with data privacy and security), opportunities (application expansion across non-medical fields,  machine learning and ai, growing focus on single-cell analysis), and challenges (prolonged timelines for approval, data interpretation challenges) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the gene expression analysis market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the gene expression analysis market
• Competitive Assessment: Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories Inc. (US), Illumina Inc (US), QIAGEN (Netherlands), F. Hoffmann-La Roche (Switzerland), Revvity (US), PacBio (US), Agilent Technologies Inc (US), Oxford Gene Technology IP Limited (UK), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc (Japan), 10x Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), NanoString Technologies Inc. (US), BioSpyder, Inc (US), Integrated DNA Technologies, Inc (US) and New England Biolabs (US), among others in the market.

Table of Contents

1            INTRODUCTION            31

1.1         STUDY OBJECTIVES      31

1.2         MARKET DEFINITION   31

1.2.1      INCLUSIONS & EXCLUSIONS     31

1.3         MARKET SCOPE             32

1.3.1      MARKETS COVERED     32

1.3.2      REGIONS COVERED      33

1.3.3      YEARS CONSIDERED     33

1.3.4      CURRENCY CONSIDERED          34

1.4         RESEARCH LIMITATIONS           34

1.5         STAKEHOLDERS            34

1.6         SUMMARY OF CHANGES            35

1.7         RECESSION IMPACT      35

2            RESEARCH METHODOLOGY     36

2.1         RESEARCH DATA           36

FIGURE 1           RESEARCH DESIGN       36

2.1.1      SECONDARY DATA       37

2.1.2      PRIMARY DATA 38

FIGURE 2           GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES        38

2.2         MARKET SIZE ESTIMATION       39

FIGURE 3           MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023              39

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023             40

FIGURE 5           ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023  40

2.2.1      INSIGHTS FROM PRIMARIES      42

FIGURE 6           MARKET VALIDATION FROM PRIMARY EXPERTS           42

2.2.2      SEGMENT ASSESSMENT (BY PRODUCT & SERVICE, APPLICATION, AND END USER)        42

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       42

2.3         GROWTH RATE ASSUMPTIONS 43

FIGURE 8           GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS (2024–2029)       44

FIGURE 9           GENE EXPRESSION ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES    44

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    45

FIGURE 10         DATA TRIANGULATION METHODOLOGY         45

2.5         STUDY ASSUMPTIONS  46

2.6         RISK ANALYSIS 46

2.7         RECESSION IMPACT ANALYSIS 46

TABLE 1             GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)         47

TABLE 2             US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)  47

TABLE 3             US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)  47

3            EXECUTIVE SUMMARY 48

FIGURE 11         GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION) 48

FIGURE 12         GENE EXPRESSION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 49

FIGURE 13         GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)             49

FIGURE 14         GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)     50

FIGURE 15         GEOGRAPHIC SNAPSHOT OF GENE EXPRESSION ANALYSIS MARKET            51

4            PREMIUM INSIGHTS      52

4.1         GENE EXPRESSION ANALYSIS MARKET OVERVIEW        52

FIGURE 16         ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET 52

4.2         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023        53

FIGURE 17         PRODUCT & SERVICE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 53

4.3         GENE EXPRESSION ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029  53

FIGURE 18         PRODUCT & SERVICE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD     53

4.4         GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           54

FIGURE 19         ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD       54

5            MARKET OVERVIEW     55

5.1         INTRODUCTION            55

5.2         MARKET DYNAMICS     55

FIGURE 20         GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    55

5.2.1      DRIVERS            56

5.2.1.1   Advancements in gene editing technologies   56

5.2.1.2   Increasing funding initiatives for genomic research      57

5.2.1.3   Growing preference for therapeutic applications          57

5.2.1.4   Declining costs of sequencing technologies    58

FIGURE 21         COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2022              59

5.2.2      RESTRAINTS     59

5.2.2.1   High cost of instruments & consumables        59

5.2.2.2   Concerns associated with data privacy and security      60

5.2.3      OPPORTUNITIES           61

5.2.3.1   High growth potential across non-clinical applications 61

5.2.3.2   Machine learning and AI    62

5.2.3.3   Growing focus on single-cell analysis             63

5.2.4      CHALLENGES   64

5.2.4.1   Extensive timelines for product approval       64

5.2.4.2   Data interpretation challenges         64

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65

FIGURE 22         REVENUE SHIFT TOWARDS GENE EXPRESSION ANALYSIS COMPANIES      65

5.4         PRICING ANALYSIS        66

5.4.1      AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT              66

TABLE 4             GENE EXPRESSION ANALYSIS PRODUCT PRICE 66

5.5         VALUE CHAIN ANALYSIS            67

FIGURE 23         GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS          68

5.6         SUPPLY CHAIN ANALYSIS          69

FIGURE 24         GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS          69

TABLE 5             GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS          70

5.7         ECOSYSTEM ANALYSIS 71

FIGURE 25         GENE EXPRESSION ANALYSIS MARKET ECOSYSTEM      71

5.7.1      GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS          72

TABLE 6             GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS           72

5.7.2      GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS              72

TABLE 7             GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS          72

5.7.3      GENE EXPRESSION ANALYSIS MARKET: END USERS       73

TABLE 8             GENE EXPRESSION ANALYSIS MARKET: END USERS       73

5.7.4      GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73

TABLE 9             GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES              73

5.8         TECHNOLOGY ANALYSIS           74

5.9         PATENT ANALYSIS        75

5.9.1      PATENTS FILED, BY DOCUMENT TYPE, 2014–2024          75

TABLE 10           PATENTS FILED, 2014–2024        75

5.9.2      INNOVATION & PATENT APPLICATIONS           75

FIGURE 26         TOTAL NUMBER OF PATENTS GRANTED, 2014–2023      75

5.9.3      TOP APPLICANTS          76

FIGURE 27         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024         76

FIGURE 28         REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024              76

TABLE 11           TOP 12 PATENT OWNERS IN GENE EXPRESSION ANALYSIS MARKET, 2014–2024       77

TABLE 12           PATENTS IN GENE EXPRESSION ANALYSIS MARKET (2024)              77

5.10       TRADE DATA    79

5.10.1    INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS              79

TABLE 13           IMPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS)              80

TABLE 14           EXPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS)              80

5.10.2    MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS         81

TABLE 15           IMPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS)           81

TABLE 16           EXPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS)           81

5.11       KEY CONFERENCES & EVENTS  82

5.11.1    GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS IN 2024–2025          82

TABLE 17           GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS (2024–2025)      82

5.12       REGULATORY LANDSCAPE       83

5.12.1    CBER REGULATIONS ON GENE EXPRESSION ANALYSIS 83

5.12.2    LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          84

TABLE 18           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         84

TABLE 19           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         85

TABLE 20           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         86

TABLE 21           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         87

5.13       PORTER’S FIVE FORCES ANALYSIS         88

TABLE 22           GENE EXPRESSION ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS         88

5.13.1    THREAT OF NEW ENTRANTS    88

5.13.2    THREAT OF SUBSTITUTES         89

5.13.3    BARGAINING POWER OF BUYERS           89

5.13.4    BARGAINING POWER OF SUPPLIERS     89

5.13.5    INTENSITY OF COMPETITIVE RIVALRY 89

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    90

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         90

FIGURE 29         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GENE EXPRESSION ANALYSIS PRODUCTS & SERVICES   90

TABLE 23           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS  90

5.14.2    BUYING CRITERIA FOR GENE EXPRESSION ANALYSIS PRODUCTS              91

FIGURE 30         KEY BUYING CRITERIA FOR END USERS              91

TABLE 24           KEY BUYING CRITERIA FOR TOP FOUR END USERS        91

6            GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE              93

6.1         INTRODUCTION            94

TABLE 25           GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       94

6.2         REAGENTS & CONSUMABLES    94

TABLE 26           GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)     95

TABLE 27           GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 95

TABLE 28           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96

TABLE 29           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96

TABLE 30           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97

TABLE 31           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97

TABLE 32           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)    97

TABLE 33           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 98

6.2.1      ASSAYS & KITS  98

6.2.1.1   Growing demand for streamlined and user-friendly solutions to drive market              98

TABLE 34           GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION)       99

TABLE 35           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            99

TABLE 36           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)  100

TABLE 37           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            100

TABLE 38           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            101

TABLE 39           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION)  101

TABLE 40           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            101

6.2.2      ENZYMES          102

6.2.2.1   High uptake in molecular techniques to drive market   102

TABLE 41           GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION)       102

TABLE 42           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)       103

TABLE 43          EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)            103

TABLE 44           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)       104

TABLE 45           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)       104

TABLE 46           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION)           104

TABLE 47           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)       105

6.2.3      DNA CHIPS        105

6.2.3.1   Rising demand across forensic research applications to propel market      105

TABLE 48           GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION)       106

TABLE 49           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)    106

TABLE 50           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)             107

TABLE 51           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)             107

TABLE 52           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)    108

TABLE 53           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION)        108

TABLE 54           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)    108

6.2.4      OTHER REAGENTS & CONSUMABLES    109

TABLE 55           GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)           109

TABLE 56           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)              110

TABLE 57           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110

TABLE 58           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)              111

TABLE 59           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)              111

TABLE 60           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)              111

TABLE 61           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)              112

6.3         INSTRUMENTS 112

TABLE 62           GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)             112

TABLE 63           GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)       113

TABLE 64           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           113

TABLE 65           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           114

TABLE 66           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           114

TABLE 67           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           115

TABLE 68           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 115

TABLE 69           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           115

6.3.1      PCR       116

6.3.1.1   Growing focus on development of novel PCR kits to boost demand          116

TABLE 70           GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION)          117

TABLE 71           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)   117

TABLE 72           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)    118

TABLE 73           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)            118

TABLE 74           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)   119

TABLE 75          MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION)  119

TABLE 76           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)   119

6.3.2      NGS      120

6.3.2.1   Increasing investments in advanced technologies to drive market             120

TABLE 77           GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION)          120

TABLE 78           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)  121

TABLE 79           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)    121

TABLE 80           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)            122

TABLE 81           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)  122

TABLE 82           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION)      122

TABLE 83           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)  123

6.3.3      DNA MICROARRAYS      123

6.3.3.1   High-throughput capabilities to propel market             123

TABLE 84           GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION, 2022–2029 (USD MILLION) 124

TABLE 85           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)  124

TABLE 86           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)            125

TABLE 87           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)            125

TABLE 88           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)  126

TABLE 89           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION 2022–2029 (USD MILLION)       126

TABLE 90           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)  126

6.3.4      OTHER INSTRUMENTS 127

TABLE 91           GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 127

TABLE 92           NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           128

TABLE 93           EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           128

TABLE 94           ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           129

TABLE 95           LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           129

TABLE 96           MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 129

TABLE 97           GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)           130

6.4         SERVICES          130

TABLE 98          GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)          130

TABLE 99           GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION)       131

TABLE 100         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       131

TABLE 101        EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)            132

TABLE 102         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       132

TABLE 103         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       133

TABLE 104         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION)           133

TABLE 105         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       133

6.4.1      GENE EXPRESSION ANALYSIS SERVICES 134

TABLE 106         GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          134

6.4.1.1   RNA sequencing services   134

6.4.1.1.1 Rising technological advancements for drug discovery development to propel market   134

TABLE 107         GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)           135

TABLE 108         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 135

TABLE 109         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)          136

TABLE 110         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)          136

TABLE 111         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137

TABLE 112         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)     137

TABLE 113         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137

6.4.1.2   Other services      138

TABLE 114         GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)  138

TABLE 115         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       139

TABLE 116         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       139

TABLE 117         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       140

TABLE 118         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       140

TABLE 119         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)           140

TABLE 120         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)       141

6.4.2      BIOINFORMATICS SOLUTIONS 141

6.4.2.1   Increasing demand for advanced data analytics to support market growth 141

TABLE 121         GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION)      142

TABLE 122         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)              142

TABLE 123         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)              143

TABLE 124         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)              143

TABLE 125         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)              144

TABLE 126         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 144

TABLE 127         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)              144

7            GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION          145

7.1         INTRODUCTION            146

TABLE 128         GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          146

7.2         DRUG DISCOVERY & DEVELOPMENT    146

7.2.1      INCREASING INVESTMENTS IN RNA-BASED THERAPEUTICS TO PROPEL MARKET          146

TABLE 129         GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)          147

TABLE 130         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              147

TABLE 131         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              148

TABLE 132         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              148

TABLE 133         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              149

TABLE 134         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)              149

TABLE 135         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              149

7.3         CLINICAL DIAGNOSTICS            150

7.3.1      RISING UTILIZATION OF MICROARRAYS FOR CANCER DETECTION TO DRIVE MARKET 150

TABLE 136         GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)  151

TABLE 137         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)        151

TABLE 138         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             152

TABLE 139         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)        152

TABLE 140         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)        153

TABLE 141         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)            153

TABLE 142         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)        153

7.4         OTHER APPLICATIONS 154

TABLE 143         GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 154

TABLE 144         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           155

TABLE 145         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           155

TABLE 146         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           156

TABLE 147         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           156

TABLE 148         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 157

TABLE 149         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           157

8            GENE EXPRESSION ANALYSIS MARKET, BY END USER    158

8.1         INTRODUCTION            159

TABLE 150         GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)     159

8.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   159

8.2.1      GROWING FOCUS ON DEVELOPMENT OF TARGETED THERAPIES TO BOOST DEMAND           159

TABLE 151         GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 160

TABLE 152         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 160

TABLE 153         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161

TABLE 154         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161

TABLE 155         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162

TABLE 156         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 162

TABLE 157         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162

8.3         ACADEMIC & RESEARCH INSTITUTES   163

8.3.1      INCREASING GOVERNMENT-FUNDED INVESTMENTS TO PROPEL MARKET            163

TABLE 158         GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 164

TABLE 159         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)              164

TABLE 160         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)              165

TABLE 161         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)              165

TABLE 162         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)              166

TABLE 163         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)              166

TABLE 164         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)              166

8.4         OTHER END USERS        167

TABLE 165        GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)  167

TABLE 166         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    168

TABLE 167         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    168

TABLE 168         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    169

TABLE 169         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    169

TABLE 170         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)        170

TABLE 171         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    170

9            GENE EXPRESSION ANALYSIS MARKET, BY REGION       171

9.1         INTRODUCTION            172

TABLE 172         GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 172

9.2         NORTH AMERICA          173

FIGURE 31         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT        173

TABLE 173         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    174

TABLE 174         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            174

TABLE 175         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         174

TABLE 176         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      175

TABLE 177         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  175

TABLE 178         NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    175

TABLE 179         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           176

TABLE 180         NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)    176

9.2.1      NORTH AMERICA: RECESSION IMPACT 176

9.2.2      US         177

9.2.2.1   Rising expenditure on NGS-based research to drive market       177

TABLE 181         US: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       177

TABLE 182         US: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)     178

TABLE 183        US: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)       178

TABLE 184         US: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)             178

TABLE 185         US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          179

TABLE 186         US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          179

TABLE 187         US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)     179

9.2.3      CANADA            180

9.2.3.1   Increasing incidence of chronic diseases to drive market            180

TABLE 188         CANADA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            180

TABLE 189         CANADA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         181

TABLE 190         CANADA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      181

TABLE 191         CANADA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  181

TABLE 192         CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             182

TABLE 193         CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           182

TABLE 194        CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          182

9.3         EUROPE             183

TABLE 195        EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          183

TABLE 196         EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   184

TABLE 197         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         184

TABLE 198         EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      184

TABLE 199        EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       185

TABLE 200         EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             185

TABLE 201         EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           185

TABLE 202         EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          186

9.3.1      EUROPE: RECESSION IMPACT   186

9.3.2      GERMANY         186

9.3.2.1   Rising investments in proteomics & genomics research to drive market    186

TABLE 203         GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            187

TABLE 204         GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         188

TABLE 205         GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      188

TABLE 206         GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  188

TABLE 207         GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       189

TABLE 208         GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           189

TABLE 209         GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)             189

9.3.3      UK         190

9.3.3.1   Favorable government support for genomic research projects to fuel market              190

TABLE 210         UK: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       191

TABLE 211         UK: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)     191

TABLE 212        UK: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)       191

TABLE 213         UK: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)             192

TABLE 214         UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          192

TABLE 215         UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          192

TABLE 216         UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          193

9.3.4      FRANCE             193

9.3.4.1   Increasing R&D in life sciences research to fuel market              193

TABLE 217         FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   194

TABLE 218         FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         194

TABLE 219         FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      194

TABLE 220        FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       195

TABLE 221         FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             195

TABLE 222         FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           195

TABLE 223         FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          196

9.3.5      ITALY   196

9.3.5.1   Favorable government support for industry-academia collaborations to support market growth     196

TABLE 224         ITALY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       197

TABLE 225         ITALY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)  197

TABLE 226         ITALY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      197

TABLE 227         ITALY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       198

TABLE 228         ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             198

TABLE 229         ITALY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           198

TABLE 230         ITALY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          199

9.3.6      SPAIN   199

9.3.6.1   Growth in biomedical research to boost demand          199

TABLE 231         SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       200

TABLE 232         SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)  200

TABLE 233         SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      200

TABLE 234         SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       201

TABLE 235         SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             201

TABLE 236         SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           201

TABLE 237         SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          202

9.3.7      REST OF EUROPE           202

TABLE 238         REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            203

TABLE 239         REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         203

TABLE 240         REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      204

TABLE 241         REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  204

TABLE 242         REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    204

TABLE 243         REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           205

TABLE 244         REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)    205

9.4         ASIA PACIFIC    205

FIGURE 32         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT        206

TABLE 245         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)       207

TABLE 246         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            207

TABLE 247         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         208

TABLE 248         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      208

TABLE 249         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  208

TABLE 250        ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       209

TABLE 251         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           209

TABLE 252         ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)             209

9.4.1      ASIA PACIFIC: RECESSION IMPACT        210

9.4.2      CHINA  210

9.4.2.1   Rising incidence of infectious diseases to boost demand             210

TABLE 253         CHINA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       211

TABLE 254         CHINA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)  211

TABLE 255         CHINA GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      211

TABLE 256         CHINA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       212

TABLE 257         CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             212

TABLE 258         CHINA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           212

TABLE 259         CHINA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          213

9.4.3      JAPAN  213

9.4.3.1   Rising technological advancements in sequencing systems to propel market              213

TABLE 260         JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       214

TABLE 261         JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)  214

TABLE 262         JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      214

TABLE 263         JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       215

TABLE 264         JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             215

TABLE 265         JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           215

TABLE 266         JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          216

9.4.4      INDIA   216

9.4.4.1   Robust growth in biopharmaceutical industry to drive market    216

TABLE 267         INDIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)       217

TABLE 268         INDIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)  217

TABLE 269         INDIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      218

TABLE 270         INDIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       218

TABLE 271         INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             218

TABLE 272         INDIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           219

TABLE 273         INDIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          219

9.4.5      AUSTRALIA       219

9.4.5.1   Increasing focus on R&D expenditure to drive market  219

TABLE 274         AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            220

TABLE 275         AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         220

TABLE 276         AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      221

TABLE 277         AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  221

TABLE 278         AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       221

TABLE 279         AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           222

TABLE 280         AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)             222

9.4.6      SOUTH KOREA 222

9.4.6.1   Rising prevalence of chronic diseases to boost demand 222

TABLE 281         SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            223

TABLE 282         SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         223

TABLE 283         SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      224

TABLE 284         SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  224

TABLE 285         SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    224

TABLE 286         SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           225

TABLE 287         SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)    225

9.4.7      REST OF ASIA PACIFIC  226

TABLE 288         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            226

TABLE 289         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 227

TABLE 290         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)            227

TABLE 291         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)        227

TABLE 292         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    228

TABLE 293         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     228

TABLE 294         REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)            228

9.5         LATIN AMERICA             229

TABLE 295         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)       229

TABLE 296         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            229

TABLE 297         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         230

TABLE 298         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      230

TABLE 299         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  230

TABLE 300         LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    231

TABLE 301         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           231

TABLE 302         LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)    231

9.5.1      LATIN AMERICA: RECESSION IMPACT   232

9.5.2      BRAZIL 232

9.5.2.1   Growth in biopharmaceutical industry to support market           232

TABLE 303         BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   233

TABLE 304         BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         233

TABLE 305         BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      233

TABLE 306         BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       234

TABLE 307         BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             234

TABLE 308         BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           234

TABLE 309         BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          235

9.5.3      MEXICO             235

9.5.3.1   Increasing incidence of diabetes and growing geriatric population to propel market              235

TABLE 310         MEXICO: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   236

TABLE 311         MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         236

TABLE 312         MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      236

TABLE 313        MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       237

TABLE 314         MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             237

TABLE 315         MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           237

TABLE 316         MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          238

9.5.4      REST OF LATIN AMERICA          238

TABLE 317         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   238

TABLE 318         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)          239

TABLE 319         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)          239

TABLE 320         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)     239

TABLE 321         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 240

TABLE 322         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  240

TABLE 323         REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)         240

9.6         MIDDLE EAST  241

TABLE 324         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)       241

TABLE 325         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            241

TABLE 326         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         242

TABLE 327         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      242

TABLE 328         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  242

TABLE 329         MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    243

TABLE 330         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           243

TABLE 331         MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)             243

9.6.1      MIDDLE EAST: RECESSION IMPACT       244

9.6.2      GCC COUNTRIES           244

TABLE 332         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    244

TABLE 333         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            244

TABLE 334         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         245

TABLE 335         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      245

TABLE 336         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  245

TABLE 337         GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    246

TABLE 338         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           246

TABLE 339         GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)    246

9.6.2.1   Saudi Arabia        247

9.6.2.1.1 Increasing investments in pharmaceutical R&D to support market growth              247

TABLE 340         SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)            247

TABLE 341         SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         248

TABLE 342         SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      248

TABLE 343         SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)  248

TABLE 344         SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    249

TABLE 345         SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           249

TABLE 346         SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)             249

9.6.2.2   United Arab Emirates        250

9.6.2.2.1 Growing R&D expenditure and advanced healthcare infrastructure to fuel market              250

TABLE 347         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   250

TABLE 348         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)          251

TABLE 349         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)          251

TABLE 350         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)     251

TABLE 351         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252

TABLE 352         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  252

TABLE 353         UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)         252

9.6.2.3   Other GCC Countries        253

TABLE 354         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   253

TABLE 355         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)          254

TABLE 356         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)          254

TABLE 357         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)     254

TABLE 358         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 255

TABLE 359         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  255

TABLE 360         OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)         255

9.6.3      REST OF MIDDLE EAST 256

TABLE 361        REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            256

TABLE 362         REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 257

TABLE 363         REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)            257

TABLE 364         REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)        257

TABLE 365         REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 258

TABLE 366        REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     258

TABLE 367        REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)            258

9.7         AFRICA 259

9.7.1      IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH        259

TABLE 368         AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)   259

TABLE 369         AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)         260

TABLE 370         AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)      260

TABLE 371         AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)       260

TABLE 372         AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             261

TABLE 373         AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           261

TABLE 374         AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)          261

9.7.2      AFRICA: RECESSION IMPACT     262

10          COMPETITIVE LANDSCAPE       263

10.1       INTRODUCTION            263

10.2       RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS        263

FIGURE 33         GENE EXPRESSION ANALYSIS: STRATEGIES DEPLOYED BY GENE EXPRESSION ANALYSIS PLAYERS 263

10.3       REVENUE SHARE ANALYSIS       264

FIGURE 34         REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021–2023)              264

10.4       MARKET SHARE ANALYSIS         264

FIGURE 35         MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)        265

TABLE 375         GENE EXPRESSION ANALYSIS MARKET: INTENSITY OF COMPETITIVE RIVALRY             265

10.5       COMPANY EVALUATION MATRIX: KEY PLAYERS            266

10.5.1    STARS  266

10.5.2    EMERGING LEADERS    266

10.5.3    PERVASIVE PLAYERS     267

10.5.4    PARTICIPANTS 267

FIGURE 36         GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023      267

10.5.5    COMPANY FOOTPRINT ANALYSIS         268

FIGURE 37         GENE EXPRESSION ANALYSIS MARKET: COMPANY FOOTPRINT (2023)        268

TABLE 376         GENE EXPRESSION ANALYSIS MARKET: TYPE FOOTPRINT              269

TABLE 377         GENE EXPRESSION ANALYSIS MARKET: REGIONAL FOOTPRINT      269

10.6       COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS      270

10.6.1    PROGRESSIVE COMPANIES       270

10.6.2    STARTING BLOCKS       270

10.6.3    RESPONSIVE COMPANIES          270

10.6.4    DYNAMIC COMPANIES 270

FIGURE 38         GENE EXPRESSION ANALYSIS MARKET: START-UP/SME EVALUATION MATRIX (2023)    271

10.7       COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS   272

TABLE 378         GENE EXPRESSION ANALYSIS MARKET: DETAILED LIST OF KEY START-UPS/SMES          272

TABLE 379         GENE EXPRESSION ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 273

10.8       VALUATION AND FINANCIAL METRICS OF GENE EXPRESSION ANALYSIS VENDORS     274

FIGURE 39         EV/EBITDA OF KEY VENDORS   274

FIGURE 40         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 274

10.9       BRAND/PRODUCT COMPARATIVE ANALYSIS    275

10.9.1    BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL           275

FIGURE 41         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL              275

10.10     COMPETITIVE SCENARIO          276

10.10.1  PRODUCT LAUNCHES  276

TABLE 380         GENE EXPRESSION ANALYSIS MARKET: PRODUCT LAUNCHES (JANUARY 2021–JANUARY 2024) 277

10.10.2  DEALS  278

TABLE 381         GENE EXPRESSION ANALYSIS MARKET: DEALS (JANUARY 2021–JANUARY 2024) 278

10.10.3  EXPANSIONS    279

TABLE 382         GENE EXPRESSION ANALYSIS MARKET: EXPANSIONS (JANUARY 2021–JANUARY 2024) 279

10.10.4  OTHER DEVELOPMENTS           280

TABLE 383         GENE EXPRESSION ANALYSIS: OTHER DEALS/DEVELOPMENTS (JANUARY 2021–JANUARY 2024)            280

11          COMPANY PROFILES    281

(Business overview, Products/Services offered, Recent developments & MnM View)*

11.1       KEY PLAYERS   281

11.1.1    THERMO FISHER SCIENTIFIC INC.          281

TABLE 384         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              281

FIGURE 42         THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT (2022)              282

TABLE 385         THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED          282

TABLE 386         THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES              288

TABLE 387         THERMO FISHER SCIENTIFIC INC.: DEALS          289

11.1.2    BIO-RAD LABORATORIES, INC. 290

TABLE 388         BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW  290

FIGURE 43         BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)              291

TABLE 389         BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED          291

TABLE 390         BIO-RAD LABORATORIES, INC.: DEALS 295

11.1.3    ILLUMINA, INC. 297

TABLE 391         ILLUMINA, INC.: COMPANY OVERVIEW 297

FIGURE 44         ILLUMINA, INC.: COMPANY SNAPSHOT (2022)  298

TABLE 392         ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED          298

TABLE 393         ILLUMINA, INC.: OTHER DEVELOPMENTS         301

11.1.4    QIAGEN             302

TABLE 394         QIAGEN: COMPANY OVERVIEW 302

FIGURE 45         QIAGEN: COMPANY SNAPSHOT (2022)  303

TABLE 395         QIAGEN: PRODUCTS/SERVICES OFFERED          303

TABLE 396         QIAGEN: PRODUCT LAUNCHES 307

TABLE 397         QIAGEN: DEALS             307

11.1.5    F. HOFFMANN-LA ROCHE LTD. 309

TABLE 398         F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 309

FIGURE 46         F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)              310

TABLE 399         F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED          310

TABLE 400         F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES 311

11.1.6    REVVITY            312

TABLE 401         REVVITY: COMPANY OVERVIEW            312

FIGURE 47         REVVITY: COMPANY SNAPSHOT (2022) 313

TABLE 402         REVVITY: PRODUCTS/SERVICES OFFERED         313

TABLE 403         REVVITY: PRODUCT LAUNCHES            315

TABLE 404         REVVITY: DEALS            315

TABLE 405         REVVITY: OTHER DEVELOPMENTS       315

11.1.7    PACBIO 316

TABLE 406         PACBIO: COMPANY OVERVIEW 316

FIGURE 48         PACBIO: COMPANY SNAPSHOT (2022)  317

TABLE 407         PACBIO: PRODUCTS/SERVICES OFFERED          317

TABLE 408         PACBIO: PRODUCT LAUNCHES 318

TABLE 409         PACBIO: DEALS 319

TABLE 410         PACBIO: OTHER DEVELOPMENTS         319

11.1.8    AGILENT TECHNOLOGIES, INC.             320

TABLE 411         AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 320

FIGURE 49         AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2023)              321

TABLE 412         AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED          321

TABLE 413         AGILENT TECHNOLOGIES, INC.: DEALS             324

TABLE 414         AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS              325

11.1.9    SYSMEX CORPORATION             326

TABLE 415         SYSMEX CORPORATION: COMPANY OVERVIEW 326

FIGURE 50         SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)  326

TABLE 416         SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED              327

TABLE 417         SYSMEX CORPORATION: DEALS             328

TABLE 418         SYSMEX CORPORATION: OTHER DEVELOPMENTS        328

11.1.10  BGI       329

TABLE 419         BGI: COMPANY OVERVIEW        329

TABLE 420         BGI: PRODUCTS/SERVICES OFFERED    330

TABLE 421         BGI: DEALS       330

11.1.11  EUROFINS SCIENTIFIC SE           331

TABLE 422         EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW           331

FIGURE 51         EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022)              331

TABLE 423         EUROFINS SCIENTIFIC SE: PRODUCTS/SERVICES OFFERED              332

TABLE 424         EUROFINS SCIENTIFIC SE: OTHER DEVELOPMENTS      332

11.1.12  STANDARD BIOTOOLS 333

TABLE 425         STANDARD BIOTOOLS: COMPANY OVERVIEW 333

FIGURE 52         STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)    334

TABLE 426         STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED              334

TABLE 427         STANDARD BIOTOOLS: PRODUCT LAUNCHES 335

11.1.13  OXFORD NANOPORE TECHNOLOGIES PLC       336

TABLE 428         OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW        336

TABLE 429         OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED            336

TABLE 430         OXFORD NANOPORE TECHNOLOGIES PLC: DEALS        337

11.1.14  GENSCRIPT       338

TABLE 431         GENSCRIPT: COMPANY OVERVIEW       338

FIGURE 53         GENSCRIPT: COMPANY SNAPSHOT       339

TABLE 432         GENSCRIPT: PRODUCTS/SERVICES OFFERED   339

TABLE 433         GENSCRIPT: OTHER DEVELOPMENTS  341

11.1.15  TAKARA BIO INC.           342

TABLE 434         TAKARA BIO INC.: COMPANY OVERVIEW           342

FIGURE 54         TAKARA BIO INC.: COMPANY SNAPSHOT (2023)             343

TABLE 435         TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED       343

TABLE 436         TAKARA BIO INC.: PRODUCT LAUNCHES           348

*Details on Business overview, Products/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.

11.2       OTHER PLAYERS           349

11.2.1    10X GENOMICS INC.      349

11.2.2    ZYMO RESEARCH CORPORATION          350

11.2.3    TWIST BIOSCIENCE       351

11.2.4    PROMEGA CORPORATION        352

11.2.5    LGC LIMITED   354

11.2.6    CD GENOMICS 355

11.2.7    NANOSTRING TECHNOLOGIES, INC.     356

11.2.8    BIOSPYDER, INC             357

11.2.9    INTEGRATED DNA TECHNOLOGIES, INC.          358

11.2.10  NEW ENGLAND BIOLABS, INC.  359

12          APPENDIX         362

12.1       DISCUSSION GUIDE      362

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             366

12.3       CUSTOMIZATION OPTIONS      368

12.4       RELATED REPORTS       368

12.5       AUTHOR DETAILS         369